Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)
China flag China · Delayed Price · Currency is CNY
39.33
0.00 (0.00%)
At close: May 6, 2026

SHE:301281 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
445.28395.19457.46445.94442.31419.67
Other Revenue
3.043.046.261.640.551.22
448.33398.23463.72447.58442.87420.89
Revenue Growth (YoY)
4.59%-14.12%3.60%1.06%5.22%14.67%
Cost of Revenue
216.15201.9266.76240.86264.82246.14
Gross Profit
232.18196.33196.96206.73178.04174.75
Selling, General & Admin
155.48131.53116.1299.7256.0363.1
Research & Development
38.1842.3535.8243.8626.9724.43
Other Operating Expenses
0.782.554.194.365.34.47
Operating Expenses
196.21178.21156.42148.2589.1492.11
Operating Income
35.9718.1240.5458.4888.9182.64
Interest Expense
-0.02-0.02-0.04---
Interest & Investment Income
6.377.0215.415.971.330.96
Currency Exchange Gain (Loss)
0.040.04-0.591.151.55-1.11
Other Non Operating Income (Expenses)
-9.290.07-2.030.09-0.320.05
EBT Excluding Unusual Items
33.6825.2453.2975.791.4782.55
Impairment of Goodwill
-0.8-0.8----
Gain (Loss) on Sale of Investments
-1.25-1.160.80.54--
Gain (Loss) on Sale of Assets
-0.26-0.26-0.840.040.37-0.04
Asset Writedown
0.7-----
Legal Settlements
-16.11-16.11-0.14---
Other Unusual Items
9.879.8712.613.456.477.41
Pretax Income
25.8216.7865.7179.7498.389.92
Income Tax Expense
1.980.45.442.77.0211.75
Earnings From Continuing Operations
23.8416.3860.2777.0491.2878.17
Minority Interest in Earnings
-0.30.180.18---
Net Income
23.5416.5560.4577.0491.2878.17
Net Income to Common
23.5416.5560.4577.0491.2878.17
Net Income Growth
-62.04%-72.62%-21.54%-15.60%16.77%13.87%
Shares Outstanding (Basic)
1101101081018181
Shares Outstanding (Diluted)
1101101081018181
Shares Change (YoY)
2.23%2.23%6.49%24.38%0.53%-0.47%
EPS (Basic)
0.210.150.560.761.120.96
EPS (Diluted)
0.210.150.560.761.120.96
EPS Growth
-62.87%-73.21%-26.32%-32.14%16.15%14.40%
Free Cash Flow
-53.15-93.58-356.9-33.1284.7531.83
Free Cash Flow Per Share
-0.48-0.85-3.31-0.331.040.39
Dividend Per Share
0.0500.0500.2000.3000.286-
Dividend Growth
-75.00%-75.00%-33.33%5.00%--
Gross Margin
51.79%49.30%42.47%46.19%40.20%41.52%
Operating Margin
8.02%4.55%8.74%13.06%20.08%19.63%
Profit Margin
5.25%4.16%13.04%17.21%20.61%18.57%
Free Cash Flow Margin
-11.86%-23.50%-76.96%-7.40%19.14%7.56%
EBITDA
83.8365.7887.4107.43122.54109.5
EBITDA Margin
18.70%16.52%18.85%24.00%27.67%26.02%
D&A For EBITDA
47.8747.6746.8648.9533.6326.86
EBIT
35.9718.1240.5458.4888.9182.64
EBIT Margin
8.02%4.55%8.74%13.06%20.08%19.63%
Effective Tax Rate
7.66%2.39%8.27%3.38%7.14%13.06%
Revenue as Reported
398.23398.23463.72447.58442.87420.89
Advertising Expenses
-4.094.031.89--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.